Eagle Asset Management’s CareDx CDNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-270,622
Closed -$4.61M 532
2022
Q3
$4.61M Sell
270,622
-7,168
-3% -$154K 0.03% 353
2022
Q2
$5.97M Buy
277,790
+5,873
+2% +$163K 0.04% 323
2022
Q1
$10.1M Buy
271,917
+14,751
+6% +$575K 0.05% 271
2021
Q4
$11.6M Sell
257,166
-39,878
-13% -$2.08M 0.05% 287
2021
Q3
$18.8M Sell
297,044
-48,298
-14% -$3.68M 0.09% 224
2021
Q2
$31.6M Buy
345,342
+4,359
+1% +$346K 0.14% 195
2021
Q1
$24M Buy
+340,983
New +$26.5M 0.11% 223

Other funds holding CDNA

Eagle Asset Management's CDNA Position: Q4 2022 in Review

Eagle Asset Management sold out of CareDx (CDNA) in Q4 2022, closing a stake of 270,622 shares — an estimated $4.61M sold.

Eagle Asset Management first reported a position in CDNA in Q1 2021 and held it in 7 quarters. The position peaked at $31.6M in Q2 2021. 168 funds tracked by Wall St. Rank hold CDNA as of Q4 2022.

  • Eagle Asset Management reported no remaining CareDx position as of Q4 2022 after selling out during the quarter.
  • Eagle Asset Management sold 270,622 CareDx shares in Q4 2022, an estimated $4.61M.
  • Eagle Asset Management first reported a position in CareDx in Q1 2021 and held it in 7 quarters.
  • Eagle Asset Management's CareDx position peaked at $31.6M in Q2 2021.
  • 168 funds tracked by Wall St. Rank held CareDx as of Q4 2022.

Based on Eagle Asset Management's 13F filing for Q4 2022, filed 14 Feb 2023.